News

March 15, 2018March 15, 2018

Endometriosis Does Not Affect Live Birth Rates in Women Who Undergo ART, Study Says

News

Endometriosis does not affect live birth rates in women who get pregnant with the help of assisted reproductive technology (ART), a review of current research shows. The study, “Endometriosis, endometrioma, ... Read more

March 14, 2018March 14, 2018

Elagolix as Combo Therapy Lessens Heavy Bleeding Linked to Uterine Fibroids, 2nd Phase 3 Study Finds

News

Results from the second Phase 3 study evaluating the potential of elagolix to treat uterine fibroids show that, when combined with low-dose hormone therapy, the experimental therapy reduces heavy menstrual bleeding, AbbVie and Neurocrine Biosciences report. Endometriosis ... Read more

March 13, 2018March 13, 2018

Molecular Links Associated With Increased Risk of MS in Endometriosis Patients

News

Researchers have found a large number of molecular links that help explain the increased risk of multiple sclerosis (MS) in women with endometriosis. Most of these shared molecular alterations are ... Read more

March 7, 2018

Actress Julianne Hough Wants Women to Speak Up for Endo in March

News

Actress Julianne Hough is encouraging women with endometriosis to share their symptoms and push for better care by taking part in AbbVie’s SpeakENDO awareness campaign. The campaign is aimed at women who want ... Read more

March 6, 2018

Endometriosis Can Affect Pain Threshold, Tolerance in Women Up to Age 46, Study Finds

News

Women with endometriosis report increased pain symptoms and reduced tolerance to pain even at a late reproductive age — up to age 46 — a study shows. These findings support ... Read more

March 2, 2018March 5, 2018

Combo Therapy Has Long-lasting Effect on Endometriosis, Study in Mice Shows

News

A combo therapy that activates a process that prevents cell death can continue helping endometriosis patients long after they stop taking it, a French study shows. The research appeared in the British ... Read more

February 28, 2018February 28, 2018

Abbvie’s Elagolix Clears Equally from Women’s Bodies Regardless of Endometriosis Status, Study Finds

News

The properties of AbbVie‘s elagolix (ABT-620), an investigative therapy for treating endometriosis and uterine fibroids, were found to be similar in women with and without endometriosis, researchers found. These findings ... Read more

February 27, 2018

New Light-Based Method May Help Distinguish Benign Ovarian Lesions from Cancer, Study Shows

News

A new method based on the way near-infrared light reflects off a sample of fluid collected from ovarian cysts may help determine the difference between benign endometriosis and cancer, a study ... Read more

February 22, 2018February 22, 2018

AbbVie’s Elagolix Reduced Heavy Menstrual Bleeding in Women with Uterine Fibroids in Phase 3 Trial

News

Results of a Phase 3 trial showed that a combination of the investigational medication elagolix with low-dose hormone therapy reduced heavy menstrual bleeding in women with uterine fibroids at six months ... Read more

February 20, 2018

Phase 3 Clinical Program Begins for Myovant’s Relugolix to Treat Endometriosis, Uterine Fibroids

News

Relugolix improved menstrual blood loss and pain associated with uterine fibroids, according to the results of two Japanese Phase 3 trials, Myovant Sciences announced. The results prompted a new Phase 3 ... Read more